Table 3.
Adverse events (reported by one trial)
| Name of trial | Adverse event | Experimental arm (N) | Control arm (N) |
| GCLLSG CLL 8 | |||
| Cytokine release syndrome grade 3/4 | 1/404 | 0/396 | |
| Haematological toxicity grade 3/4 | 225/404 | 157/396 | |
| Leukocytopenia grade 3/4 | 97/404 | 48/396 | |
| Tumour lysis syndrome grade 3/4 | 1/404 | 2/396 | |
| Autoimmune haemolytic anaemia | 22/404 | 27/396 | |
| Infection | 103/404 | 85/396 | |
| REACH | |||
| Febrile neutropenia grade 3/4 | 33/274 | 32/272 | |
| Granulocytopenia grade 3/4 | 18/274 | 12/272 | |
| Hepatitis B grade 3/4 | 0/274 | 5/272 | |
| Pancytopenia grade 3/4 | 9/274 | 13/272 | |
| Pneumonia | 15/274 | 17/272 |